about
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cellsMitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alphaUridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat.Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in miceQuality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.Thermogenic activation induces FGF21 expression and release in brown adipose tissue.Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyPeroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16.Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes.The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell LineagesFibroblast growth factor 21 in breast milk controls neonatal intestine function.Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients.Impaired expression of mitochondrial and adipogenic genes in adipose tissue from a patient with acquired partial lipodystrophy (Barraquer-Simons syndrome): a case report.SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD.The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology.Pharmacological and gene modification-based models for studying the impact of perinatal metabolic disturbances in adult life.Adipose tissue biology and HIV-infection.White, brown, beige/brite: different adipose cells for different functions?Thermogenic brown and beige/brite adipogenesis in humans.Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPδ.Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.Adipokines and the Endocrine Role of Adipose Tissues.Fibroblast growth factor-21, energy balance and obesity.Mitochondrial Uncoupling and the Regulation of Glucose Homeostasis.Brown adipose tissue as a secretory organ.Transcriptional regulation of the uncoupling protein-1 gene.Hormonal and nutritional signalling in the control of brown and beige adipose tissue activation and recruitment.FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling.Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation.TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.Improved adipose tissue function with initiation of protease inhibitor-only ART.Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines.Influence of thyroid hormones on the human ATP synthase beta-subunit gene promoter.Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.Opposing actions of Fos and Jun on transcription of the phosphoenolpyruvate carboxykinase (GTP) gene. Dominant negative regulation by Fos.Fibroblast growth factor 21 protects the heart from oxidative stress.
P50
Q24674939-774082F1-04BC-4838-B73F-EF584409BF7DQ28589833-DC0BFBC8-EF75-4757-9E81-AFBD83205101Q33749881-33E3A77C-DC50-4CAF-93A2-86658B73DC77Q33762194-D54B9841-9571-4E29-A7E1-5DFAF6B3598BQ34117877-D8232E22-066E-48CB-8DAE-22482454728FQ34785931-B618014D-51BE-43CF-B758-E8C98D406DDEQ34787051-16D4C60F-D42E-4380-A7DD-DFA54C9A0974Q35106654-41661587-AFB1-4CAF-A1F7-B1D526A2BC70Q35604665-73357216-D679-4476-82DB-E87D931EDF5CQ35699658-B8C86EDA-1C26-4E63-868F-6AABFD8085CBQ35754572-17DEA4BF-8B7C-451D-AC3C-F55FAB9C4894Q36018146-9A42EB76-DF3E-435E-ACCA-66DB4C9504F5Q36024373-D7BBA253-C0C0-4BF0-81A1-E64B09F3E962Q36375948-93AD0E62-04F1-47E1-B72F-48159AAA7E08Q36870336-1A3101B1-8600-4B19-A695-43C835984E65Q37372145-64D92B14-F649-4B7D-9AB2-9D7A7A9C2B20Q37427682-FD429D45-034D-4F58-8612-E92BB597734DQ37492211-F19E361A-247F-46ED-95E6-C914B8DC6059Q37523520-B4F9B4C4-92C2-4A71-925F-C0D588D3EA2CQ37887889-6E3F2B54-8ADE-4B2D-A291-9213E1F5C6BDQ38115665-254F1C1B-4CDE-4FFB-B89D-67BEA5CDE863Q38250563-299684AF-2921-47E2-84CC-A783B8849200Q38327840-E889E3D3-BF33-49F4-BA2F-6816049AD237Q38374994-4AB9EAC8-ACB1-44CF-B8F9-E9BAE83E4FCBQ38392464-D41C0529-52C5-495B-9147-311A71842CF4Q38436220-0526DFFF-55EE-46D9-9130-58669F02A372Q38594676-46AB36C6-7E68-4F8D-BDB0-955929AED626Q38743510-96789470-B104-4BD9-A67C-A046A60A7767Q38951456-31FA3296-8047-4C03-B936-8EEC93DFB3F1Q38969645-EC0E6384-EDC7-412C-A269-B12F261E8800Q38970968-96AFFDB2-9BB3-47EA-A960-39CF250E88EFQ38972403-809F3414-B4A7-4E45-B793-48A5F2086633Q38981088-FA3C8942-E293-4083-8FE9-2BFA1A5392C1Q39317227-FFA1E87E-129C-4187-AE5F-5A4CD47857B4Q40578427-00792CE3-BBF6-48AE-82EC-D6C5A01FBF22Q40662536-B5ABF015-766F-44A6-A277-BCD5863B7DBBQ41236959-3EAA6D66-21B6-4A42-B670-467770BBC08AQ41380838-4914BF31-D5B8-408B-9D2F-B39DB3FC18D0Q41603706-F87AD313-C04F-4527-9054-CC915716EEF0Q41652869-C48E8480-5E89-4A30-B4F0-9C490A8CAFFD
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Marta Giralt
@ast
Marta Giralt
@en
Marta Giralt
@es
Marta Giralt
@nl
Marta Giralt
@sl
type
label
Marta Giralt
@ast
Marta Giralt
@en
Marta Giralt
@es
Marta Giralt
@nl
Marta Giralt
@sl
prefLabel
Marta Giralt
@ast
Marta Giralt
@en
Marta Giralt
@es
Marta Giralt
@nl
Marta Giralt
@sl
P214
P950
P1053
A-4756-2013
P106
P1153
7103204617
P1580
P21
P213
0000 0000 6020 6132
P214
P31
P3829
P496
0000-0001-7968-4190
P735
P7859
viaf-307164478